IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-5878

  1. 1,273 Posts.
    lightbulb Created with Sketch. 739
    I originally took it as neutral, until it clicked that now this Phase2b can be classified as multi site pivotal study that will meet the criteria for FDA approval should the results be what we are expecting.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.